ZHAOKE OPHTH-B

06622
2.0154.05% ( -0.085 )
Delay Closed: Nov 17, 16:08:15

Valuation

Current ValuationThe current P/E ratio is -4.47, within the reasonable range, cheaper than 57.82% of the time in the past 5 years, and the industry ranks 40/53, the industry Median 6.96.

-4.47xP/E
Stock priceHK$2.02Earnings per shareHK$-0.45

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.96x
010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.96x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
06887HKSUNSHINE PHARMA
-63.90x--HK$20.96B
02630HKVIGONVITA-B
-35.68x--HK$12.52B
09637HKALEBUND-B
-8.56x48.51%HK$6.94B
00570HKTRAD CHI MED
-4.85x223.71%HK$5.64B
02575HKXUANZHUBIO-B
-17.24x--HK$4.17B
01477HKOCUMENSION-B
-27.28x52.42%HK$3.94B
01349HKFUDANZHANGJIANG
-19.59x--HK$2.35B
02552HKHUA MEDICINE-B
-17.58x104.78%HK$2.18B
02652HKCF PHARMTECH
-256.41x--HK$2.00B
06622HKZHAOKE OPHTH-B
-4.47x--HK$1.11B
01652HKFUSEN PHARM
-224.00x--HK$598.83M
01011HKNT PHARMA
-15.28x--HK$485.07M
01643HKMODERN CHI MED
-6.71x--HK$324.00M
00575HKREGENT PACIFIC
-14.11x--HK$215.94M
08329HKNEP INTERLONG
-3.48x--HK$211.43M
01312HKKONTA CHINA
-0.76x--HK$162.07M
00455HKTIANDA PHARMA
-2.34x--HK$161.25M
00858HKEXTRAWELL PHAR
-0.16x--HK$159.50M
01498HKPURAPHARM
-4.17x--HK$115.22M
01889HKSANAI HEALTH GP
-1.01x--HK$22.63M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.